Ibiome Biology

About:

Ibiome Biology is an intestinal bacteria drug developer focusing on research & development of microorganisms and metabolite pharmaceuticals.

Website: http://m.ibiome.com.cn

Top Investors: CICC Capital

Description:

Ibiome Biology is an intestinal bacteria drug developer that focuses on the research and development of gut-brain axis living microorganisms and metabolite pharmaceuticals.

Total Funding Amount:

100M CNY

Headquarters Location:

Hefei, Anhui, China

Founded Date:

2021-01-01

Contact Email:

hr(AT)ibiome.com.cn

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-11-20

IPO Status:

Private

Industries: